FAILED
首站-论文投稿智能助手
典型文献
Development and application of bionic systems consisting of tumor-cell membranes
文献摘要:
Malignant tumors pose a serious threat to human health but during the past decade,great progress has been made in the treatment of tumors.The tumor-cell membrane is well constructed and can be used to solve problems in tumor therapy.Tumor-cell membranes exhibit not only high biocompatibility due to their homology but also enhanced therapeutic effects when combined with nanotechnology.Meanwhile,nanoma-terials show high selectivity,sensitivity,and clinical transformation potential.Enhanced immunotherapy or tumor vaccines have potential clinical application because of tumor-membrane surface-specific antigens.Several studies have confirmed the feasibility and ad-vantages of using tumor-cell membrane-incorporated nanosystems for tumor therapy.Considering all this,we focus in this review on the application of tumor-cell-membrane bionic platforms and,in the summary,provide ideas for new scientific developments.
文献关键词:
作者姓名:
Tianjiao PENG;Jun YAO
作者机构:
Clinical Medical College,Henan University of Science and Technology,Luoyang 471003,China;Department of Oncology,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471003,China;Epigenetics and Molecular Biology Laboratory,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471003,China
引用格式:
[1]Tianjiao PENG;Jun YAO-.Development and application of bionic systems consisting of tumor-cell membranes)[J].浙江大学学报(英文版)(B辑:生物医学和生物技术),2022(09):770-777
A类:
B类:
Development,application,bionic,consisting,cell,membranes,Malignant,tumors,pose,serious,threat,human,health,but,during,past,decade,great,progress,has,been,made,treatment,well,constructed,can,used,solve,problems,Tumor,exhibit,only,high,biocompatibility,due,their,homology,also,enhanced,therapeutic,effects,when,combined,nanotechnology,Meanwhile,nanoma,terials,show,selectivity,sensitivity,clinical,transformation,potential,Enhanced,immunotherapy,vaccines,have,because,surface,specific,antigens,Several,studies,confirmed,feasibility,vantages,using,incorporated,nanosystems,Considering,all,this,focus,review,platforms,summary,provide,ideas,new,scientific,developments
AB值:
0.658669
相似文献
Identification of sitagliptin binding proteins by affinity purification mass spectrometry
Xue-Ning Wang;Byu-Ri Sim;Hong Chen;Yun-Xiao Zheng;Jun-Biao Xue;Lei Wang;Wei-Sha Kong;Kuan Zhou;Shu-Juan Guo;Jing-Li Hou;Jiong Zhang;He-Wei Jiang;Sheng-Ce Tao-Shanghai Center for Systems Biomedicine,Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Jiao Tong University,Shanghai 200240,China;State Key Laboratory of Microbial Metabolism,Joint International Research Laboratory of Metabolic and Developmental Sciences,MOE-LSB&MOE-LSC,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;Instrumental Analysis Center,Shanghai Jiao Tong University,Shanghai 200240,China,41nflammation and Immune Mediated Diseases Laboratory of Anhui Province,School of Pharmacy,Anhui Medical University,Hefei 230032,China;Key Laboratory of Organofluorine Chemistry,Center for Excellence in Molecular Synthesis,Shanghai Institute of Organic Chemistry,University of the Chinese Academy of Sciences,Chinese Academy of Sciences,Shanghai 200032,China.
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Yi Xiao;Ding Ma;Yun-Song Yang;Fan Yang;Jia-Han Ding;Yue Gong;Lin Jiang;Li-Ping Ge;Song-Yang Wu;Qiang Yu;Qing Zhang;Francois Bertucci;Qiuzhuang Sun;Xin Hu;Da-Qiang Li;Zhi-Ming Shao;Yi-Zhou Jiang-Key Laboratory of Breast Cancer in Shanghai,Department of Breast Surgery,Fudan University Shanghai Cancer Center;Department of Oncology,Shanghai Medical College,Fudan University,Shanghai,China;Human Phenome Institute,Fudan University,Shanghai,China;Department of Pathology,University of Texas Southwestern Medical Center,Dallas,TX,USA;Predictive Oncology team,Centre de Recherche en Cancérologie de Marseille(CRCM),INSERM UMR1068,CNRS UMR725,Aix-Marseille Université,Institut Paoli-Calmettes,Marseille,France;Department of Industrial Systems Engineering and Management,National University of Singapore,Singapore,Singapore
Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy
Shuangquan Gou;Nanxi Chen;Xiaoai Wu;Menghang Zu;Shixiong Yi;Binwu Ying;Fangyin Dai;Bowen Ke;Bo Xiao-Laboratory of Anesthesiology & Critical Care Medicine,Department of Anesthesiology,West China Hospital,Sichuan University,Chengdu 610041,China;State Key Laboratory of Silkworm Genome Biology,College of Sericulture,Textile and Biomass Sciences,Southwest University,Chongqing 400715,China;Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing,School of Materials and Energy,Southwest University,Chongqing 400715,China;Department of Nuclear Medicine,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Laboratory Medicine,West China Hospital,Sichuan University,Chengdu 610041,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。